Nanoscale BioPhotonics Laboratory, School of Chemistry, National University of Ireland, Galway, H91 CF50, Ireland.
Nanoscale BioPhotonics Laboratory, School of Chemistry, National University of Ireland, Galway, H91 CF50, Ireland.
Anal Chim Acta. 2020 Nov 22;1138:18-29. doi: 10.1016/j.aca.2020.09.007. Epub 2020 Sep 8.
Being able to measure the size and distribution of oligomers in solution is a critical issue in the manufacture and stability of insulin and other protein formulations. Measuring oligomers reliably can however be complicated, due to their fragile self-assembled structures, which are held together by weak forces. This can cause issues in chromatographic based methods, where dissociation or re-equilibration of oligomer populations can occur e.g. upon dilution in a different eluting buffer, but also for light scattering based methods like dynamic light scattering (DLS) where the size difference involved (often less than a factor 3) does not allow mixtures of oligomers to be resolved. Intrinsic fluorescence offers an attractive alternative as it is non-invasive, sensitive but also because it contains scattered light when implemented via excitation emission matrix (EEM) measurements, that is sensitive to changes in particle size. Here, using insulin at formulation level concentrations, we show for the first time how EEM can both discriminate and quantify the proportion of oligomeric states in solution. This was achieved by using the Rayleigh scatter (RS) band and the fluorescence signal contained in EEM. After validating size changes with DLS, we show in particular how the volume under the RS band correlated linearly with protein/oligomer molecular weight, in agreement with the Debye-Zimm relationship. This was true for the RS data from both EEM and polarized EEM (pEEM) measurements, the latter providing a stronger scatter signal, more sensitive to particle size changes. The fluorescence signal was then used with multivariate curve resolution (MCR) to quantify more precisely the soluble oligomer composition of insulin solutions. In conditions that promoted the formation of mainly one type of oligomer (monomer, dimer, or hexamer), pEEM-MCR helped identify the presence of small amounts of other oligomeric forms, while in conditions that were previously said to favour the insulin tetramer, we show that in the presence of zinc, these insulin samples were instead a heterogenous mixture composed of mostly dimers and hexamers. These MCR results correlated in all cases with the observed discrimination by principal component analysis (PCA), and deviations observed in the RS data. In conclusion, using pEEM scatter and emission components with chemometric data analysis provides a unique analytical method for characterising and monitoring changes in the soluble oligomeric state of proteins.
能够测量溶液中寡聚物的大小和分布是胰岛素和其他蛋白质制剂制造和稳定性的关键问题。然而,由于其脆弱的自组装结构,这些结构由弱力保持在一起,因此可靠地测量寡聚物可能会很复杂。这可能会导致基于色谱的方法出现问题,例如在不同洗脱缓冲液中稀释时,寡聚物群体可能会发生解离或重新平衡,也可能导致基于光散射的方法(如动态光散射 (DLS))出现问题,因为所涉及的大小差异(通常小于 3 倍)不允许分辨寡聚物的混合物。本征荧光提供了一种有吸引力的替代方法,因为它是非侵入性的、灵敏的,而且因为当通过激发发射矩阵 (EEM) 测量实施时,它包含散射光,这对颗粒大小的变化敏感。在这里,我们首次使用胰岛素制剂浓度证明了 EEM 如何既能区分又能定量溶液中寡聚态的比例。这是通过使用瑞利散射 (RS) 带和 EEM 中包含的荧光信号来实现的。在用 DLS 验证大小变化后,我们特别展示了如何与蛋白质/寡聚物分子量线性相关的 RS 带下的体积,这与德拜-齐姆关系一致。这对于来自 EEM 和偏振 EEM (pEEM) 测量的 RS 数据都是如此,后者提供了更强的散射信号,对颗粒大小变化更敏感。然后,荧光信号与多元曲线分辨率 (MCR) 一起用于更精确地量化胰岛素溶液中可溶性寡聚物的组成。在促进主要形成一种类型寡聚物(单体、二聚体或六聚体)的条件下,pEEM-MCR 有助于识别少量其他寡聚形式的存在,而在先前被认为有利于胰岛素四聚体的条件下,我们表明,在锌存在的情况下,这些胰岛素样品相反是由主要为二聚体和六聚体组成的异质混合物。在所有情况下,这些 MCR 结果都与主成分分析 (PCA) 的观察到的区分相关,并且与 RS 数据中的偏差相关。总之,使用 pEEM 散射和发射成分与化学计量数据分析相结合,为蛋白质可溶性寡聚态的特征描述和监测提供了一种独特的分析方法。